These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4781011)

  • 1. Combined use of glucagon and beta-adrenoceptor antagonists in ventricular arrhythmias accompanying myocardial infarction.
    Madan BR; Jain BK
    Indian J Med Res; 1973 Oct; 61(10):1535-43. PubMed ID: 4781011
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lidocaine and practolol therapy of infarction caused arrhythmias].
    Stephan K; Meesmann W; Wild U; Lattke F; Bischoff KO
    Verh Dtsch Ges Inn Med; 1973; 79():983-6. PubMed ID: 4790062
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of beta-blocking agents in acute cardiac infarct].
    Mangiameli S; Circo A; Galassi A
    Boll Soc Ital Cardiol; 1975; 20(4):315-9. PubMed ID: 1231910
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-adrenergic blockade for survivors of acute myocardial infarction.
    Frishman WH; Furberg CD; Friedewald WT
    N Engl J Med; 1984 Mar; 310(13):830-7. PubMed ID: 6142420
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of lidocaine-resistant arrhythmias following experimentally severe heart infarct by supplementary sympathicolysis, especially with atenolol].
    Abendroth RR; Hübner H; Stephan K; Meesmann W
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():211-5. PubMed ID: 77107
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta blocking drugs as anti-arrhythmic agents.
    Fitzgerald JD
    Int J Clin Pharmacol Biopharm; 1975 Apr; 11(3):235-44. PubMed ID: 238912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glucagon therapy in acute myocardial infarct with recurring ventricular tachycardia and left ventricular failure].
    Berlind S; Lindholm L; Prellner K
    Lakartidningen; 1972 Nov; 69(46):5312-4. PubMed ID: 4650736
    [No Abstract]   [Full Text] [Related]  

  • 8. Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Part B.
    Wit AL; Hoffman BF; Rosen MR
    Am Heart J; 1975 Nov; 90(5):665-75. PubMed ID: 242208
    [No Abstract]   [Full Text] [Related]  

  • 9. [Beta-adrenergic blocking agents in the treatment of painful ischemic cardiopathy].
    Dimitriu CG; Manu P
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1976; 28(2):97-103. PubMed ID: 4877
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects on the contractile state of the myocardium and anti-arrhythmic properties of practolol, a beta-blocking agent with cardioselective activity].
    Di Luzio V; Purcaro A; Curzi G; Di Segni E; Chiesa R; Di Giuseppe F
    Boll Soc Ital Cardiol; 1972; 17(3):179-87. PubMed ID: 4671753
    [No Abstract]   [Full Text] [Related]  

  • 11. Superiority of practolol versus propranolol in protection against ventricular fibrillation induced by coronary occlusion.
    Pearle DL; Williford D; Gillis RA
    Am J Cardiol; 1978 Dec; 42(6):960-4. PubMed ID: 727146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Propranolol and propranolol-glucagon in the geriatric age. Clinico-therapeutic considerations].
    Nardoni A; Bulfoni A
    Clin Ter; 1975 May; 73(4):343-51. PubMed ID: 1220886
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-arrhythmic effect of DL-propranolol, D-propranolol and I. C. I. 50 172 in experimental myocardial infarction in the dog.
    Staszewska-Barczak J
    Acta Physiol Pol; 1970; 21(3):260-70. PubMed ID: 4396953
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of various beta-adrenergic blockers in clinical anesthesia. (5) Clinical and experimental use of practolol (Eraldin)].
    Miyazaki M; Nioka S; Fujita T
    Masui; 1975 Jan; 24(1):56-63. PubMed ID: 1168741
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental studies on the use of beta-sympatholytics in infarct-induced ventricular fibrillation].
    Schley G; Meesmann W; Wild U
    Med Welt; 1975 Jul; 26(27-28):1313-5. PubMed ID: 1177696
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of adrenergic beta receptor blockaders in myocardial infarct].
    Florkiewicz H; Rymar B; Przegaliński J; Markiewicz M
    Pol Tyg Lek; 1980 Jun; 35(23):853-5. PubMed ID: 6997844
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of a selective beta adrenergic blocking agent on ventricular arrhythmias in the first year following myocardial infarction.
    Federman J; Whitford JA; Anderson ST; Pitt A
    Aust N Z J Med; 1980 Jun; 10(3):289-94. PubMed ID: 6996660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practolol in cardiac arrhythmias.
    Kundu SC; De AK; Majumdar S
    J Indian Med Assoc; 1974 Aug; 63(4):113-9. PubMed ID: 4436563
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of drugs used in management of arrhythmias developing after acute myocardial infarction.
    Jewitt DE; Mercer CJ; Hubner PJ; Shillingford JP
    Br Heart J; 1969 Nov; 31(6):794. PubMed ID: 5358169
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of beta adrenergic blocking on the arrhythmias following coronary ligation in rat.
    Kenedi I; Losonci A
    Acta Physiol Acad Sci Hung; 1973; 44(3-4):247-57. PubMed ID: 4143381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.